Ginkgetin

Ginkgetin is a lipid of Polyketides (PK) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 299 references associated with Ginkgetin in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for Ginkgetin

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Ginkgetin

MeSH term MeSH ID Detail
Adenocarcinoma D000230 166 associated lipids
Dermatitis D003872 30 associated lipids
Total 2

NCBI Entrez Crosslinks

All references with Ginkgetin

Download all related citations
Per page 10 20 50 | Total 49
Authors Title Published Journal PubMed Link
pmid:
Krauze-Baranowska M Flavonoids from Metasequoia glyptostroboides. 2004 May-Jun Acta Pol Pharm pmid:15481245
Hayashi K et al. Mechanism of action of the antiherpesvirus biflavone ginkgetin. 1992 Antimicrob. Agents Chemother. pmid:1329635
Kim HP et al. Biochemical pharmacology of biflavonoids: implications for anti-inflammatory action. 2008 Arch. Pharm. Res. pmid:18409037
Lim H et al. Effects of anti-inflammatory biflavonoid, ginkgetin, on chronic skin inflammation. 2006 Biol. Pharm. Bull. pmid:16651744
Son JK et al. Ginkgetin, a Biflavone from Ginko biloba leaves, inhibits cyclooxygenases-2 and 5-lipoxygenase in mouse bone marrow-derived mast cells. 2005 Biol. Pharm. Bull. pmid:16327145
Cao J et al. Ginkgetin inhibits growth of breast carcinoma via regulating MAPKs pathway. 2017 Biomed. Pharmacother. pmid:29031204
Lian N et al. Ginkgetin ameliorates experimental atherosclerosis in rats. 2018 Biomed. Pharmacother. pmid:29579712
Ryu YB et al. Biflavonoids from Torreya nucifera displaying SARS-CoV 3CL(pro) inhibition. 2010 Bioorg. Med. Chem. pmid:20934345
Sasaki H et al. beta-Secretase (BACE-1) inhibitory effect of biflavonoids. 2010 Bioorg. Med. Chem. Lett. pmid:20598535
Miki K et al. Anti-influenza virus activity of biflavonoids. 2007 Bioorg. Med. Chem. Lett. pmid:17110111
Lee MK et al. Osteoblast differentiation stimulating activity of biflavonoids from Cephalotaxus koreana. 2006 Bioorg. Med. Chem. Lett. pmid:16574412
You OH et al. Ginkgetin induces apoptosis via activation of caspase and inhibition of survival genes in PC-3 prostate cancer cells. 2013 Bioorg. Med. Chem. Lett. pmid:23523142
Kang SS et al. Neuroprotective effects of naturally occurring biflavonoids. 2005 Bioorg. Med. Chem. Lett. pmid:15978805
Moirangthem DS et al. Antioxidant, antibacterial, cytotoxic, and apoptotic activity of stem bark extracts of Cephalotaxus griffithii Hook. f. 2012 BMC Complement Altern Med pmid:22469333
Farooqui M et al. COX-2 inhibitor celecoxib prevents chronic morphine-induced promotion of angiogenesis, tumour growth, metastasis and mortality, without compromising analgesia. 2007 Br. J. Cancer pmid:17971769
Jeon YJ et al. Ginkgetin inhibits the growth of DU-145 prostate cancer cells through inhibition of signal transducer and activator of transcription 3 activity. 2015 Cancer Sci. pmid:25611086
Hyun SK et al. Biflavone glucosides from Ginkgo biloba yellow leaves. 2005 Chem. Pharm. Bull. pmid:16141598
Mercader AG and Pomilio AB QSAR study of flavonoids and biflavonoids as influenza H1N1 virus neuraminidase inhibitors. 2010 Eur J Med Chem pmid:20116898
Li J et al. A new dilactone from the seeds of Gaultheria yunnanensis. 2010 Fitoterapia pmid:19628028